首页> 外国专利> PROCESS FOR THE PURIFICATION OF FACTOR VII POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS

PROCESS FOR THE PURIFICATION OF FACTOR VII POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS

机译:使用包含特定配体的亲和力树脂纯化因子VII多肽的方法

摘要

The invention concerns a process for the purification of a drug substance of a Factor VII polypeptide, said process comprising the steps of: (a) contacting the drug substance with an affinity resin under conditions which facilitate binding of a portion of said drug substance to said affinity resin; (b) optionally washing said affinity resin containing bound drug substance with a washing buffer; and (c) eluting said affinity resin containing bound drug substance with an elution buffer, and collecting a purified drug substance of the Factor VII polypeptide as an eluate; wherein said affinity resin is a solid phase material having covalently immobilized thereto one or more ligands of the general formula (I), wherein each of R1, R2 and R3 represents an organic moiety of a molecular weight of 15-1000 g/mol, the total molecular weight of said ligand being 200- 2000 g/mol; said ligand being immobilized to said solid phase material via one of said organic moieties R1, R2 and R3.
机译:本发明涉及纯化因子VII多肽的药物的方法,所述方法包括以下步骤:(a)在有利于所述药物部分与所述药物结合的条件下使药物与亲和树脂接触。亲和树脂(b)任选地用洗涤缓冲液洗涤所述含有结合药物的亲和树脂。 (c)用洗脱缓冲液洗脱含有结合的药物的所述亲和树脂,并收集纯化的因子VII多肽的药物作为洗脱液;其中所述亲和树脂是具有共价固定于其上的一种或多种通式(I)的配体的固相材料,其中R1,R2和R3各自表示分子量为15-1000 g / mol的有机部分,所述配体的总分子量为200-2000g / mol;所述配体通过所述有机部分R1,R2和R3之一固定在所述固相材料上。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号